Literature DB >> 8916935

Involvement of p21cip-1 and p27kip-1 in the molecular mechanisms of steel factor-induced proliferative synergy in vitro and of p21cip-1 in the maintenance of stem/progenitor cells in vivo.

C Mantel1, Z Luo, J Canfield, S Braun, C Deng, H E Broxmeyer.   

Abstract

Steel factor (SLF) is a hematopoietic cytokine that synergizes with other growth factors to induce a greatly enhanced proliferative state of hematopoietic progenitor cells and factor-dependent cell lines. Even though the in vivo importance of SLF in the maintenance and responsiveness of stem and progenitor cells is well documented, the molecular mechanism involved in its synergistic effects are mainly unknown. Some factor-dependent myeloid cell lines respond to the synergistic proliferative effects of SLF plus other cytokines in a manner similar to that of normal myeloid progenitor cells from bone marrow and cord blood. We show here that SLF can synergize with granulocyte-macrophage colony-stimulating factor (GM-CSF) to induce an enhanced phosphorylation of the retinoblastoma gene product and a synergistic increase in the total intracellular protein level of the cyclin-dependent kinase inhibitor, p21cip-1, which is correlated with a simultaneous decrease in p27kip-1 in the human factor-dependent myeloid cell line, M07e. Moreover, these cytokines synergize to increase p21cip-1 binding and decrease p27kip-1 binding to cyclin-dependent kinase-2 (cdk2), an enzyme required for normal cell cycle progression; these inverse events correlated with increased cdk2 kinase activity. It is also shown that exogenous purified p21cip-1 can displace p27kip-1 already bound to cdk2 in vitro. These data implicate increased p21cip-1 and decreased p27kip-1 intracellular concentrations and their stoichiometric interplay in the enhanced proliferative status of cells stimulated by the combination of SLF and GM-CSF. In support of these findings, it is shown that hematopoietic progenitor cells from mice lacking p21cip-1 are defective in SLF synergistic proliferative response in vitro. Moreover, the cycling status of marrow and spleen progenitors and absolute numbers of marrow progenitors were significantly decreased in the p21cip-1 -/-, compared with the +/+ mice. We conclude that the cdk threshold regulators p21cip-1 and p27kip-1 play a critical role in the normal mitogenic response of M07e cells and murine myeloid progenitor cells to these cytokines and particularly in the SLF synergistic proliferative response that is important to the normal maintenance of the stem/progenitor cell compartment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8916935

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

1.  A repertoire of cell cycle regulators whose expression is coordinated with human cytotrophoblast differentiation.

Authors:  O Genbacev; M T McMaster; S J Fisher
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Cyclin dependent kinase inhibitors differentially modulate synergistic cytokine responsiveness of hematopoietic progenitor cells.

Authors:  Hal E Broxmeyer; David S Franklin; Scott Cooper; Giao Hangoc; Charlie Mantel
Journal:  Stem Cells Dev       Date:  2011-11-02       Impact factor: 3.272

3.  Hematopoiesis and thymic apoptosis are not affected by the loss of Cdk2.

Authors:  Cyril Berthet; Maria Cecilia Rodriguez-Galan; Deborah L Hodge; John Gooya; Véronique Pascal; Howard A Young; Jonathan Keller; Remy Bosselut; Philipp Kaldis
Journal:  Mol Cell Biol       Date:  2007-05-07       Impact factor: 4.272

4.  A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase.

Authors:  J A Diehl; C J Sherr
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

5.  Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells.

Authors:  L Rössig; A S Jadidi; C Urbich; C Badorff; A M Zeiher; S Dimmeler
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 6.  p21 in cancer: intricate networks and multiple activities.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

Review 7.  Enhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function.

Authors:  Hal E Broxmeyer
Journal:  Ann N Y Acad Sci       Date:  2012-08       Impact factor: 5.691

Review 8.  Oncogenic role of p21 in hepatocarcinogenesis suggests a new treatment strategy.

Authors:  Shogo Ohkoshi; Masahiko Yano; Yasunobu Matsuda
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

9.  Estrogen stimulates expression of p21Waf1/Cip1 in mouse uterine luminal epithelium.

Authors:  Ming-Derg Lai; Meei Jyh Jiang; Lih-Yuh C Wing
Journal:  Endocrine       Date:  2002-04       Impact factor: 3.633

10.  Adaptation: paradigm for the gut and an academic career.

Authors:  Brad W Warner
Journal:  J Pediatr Surg       Date:  2013-01       Impact factor: 2.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.